文献速递神经肿瘤

术前IDH突变低级别胶质瘤患者D-2-羟基戊二酸及其他代谢物的波谱成像

Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas.
PubMed 文献 · J Neurooncol · 2022-06-08

研究对45例2级和3级胶质瘤患者术前进行2HG特异性3-D MR波谱成像,比较代谢物与分子病理、分级、组织学亚型的关系,并评估其对无进展生存期(PFS)的预测作用。结果显示2HG表观检出准确率为91.1%,2HG/tCr升高(HR 5.594)及≥0.905阈值预测不良PFS。

要点

  • 2HG在39/42(93%)IDH+和1/3(33%)IDH-患者中可定量,表观检出准确率91.1%。
  • 肌醇/总胆碱在星形细胞型、p53突变和3级IDH突变胶质瘤中降低(p<0.05)。
  • 2HG/tCr升高(p=0.0007,HR 5.594)及≥0.905阈值(p=0.02)预测不良PFS。

核心结论

  • 在体2HG检测可在临床扫描仪上合理实现,2HG水平升高可能提示不良PFS。

研究设计与样本

  • 45例患者接受术前MRI,包括针对2HG检测优化的3-D波谱成像。
  • 波谱数据经重建和量化,按分子病理(IDH1R132H、1p/19q、p53)、胶质瘤分级、组织学亚型及T2病灶与正常表现白质(NAWM)ROI比较代谢物水平。
  • 采用Pearson相关检验分析2HG与其他代谢物及图像引导组织样本病理参数(细胞密度、MIB-1)的相关性。
  • 采用Cox比例风险模型评估预测PFS的代谢物。

主要发现

  • 2HG在39/42(93%)IDH+和1/3(33%)IDH-患者中可定量,表观检出准确率91.1%。
  • 肌醇/总胆碱在星形细胞型(1p/19q野生型)、p53突变和3级(vs. 2级)IDH突变胶质瘤中降低(p<0.05),这些组均显示较高比例的星形细胞瘤。
  • 与NAWM相比,T2病灶显示2HG+γ-氨基丁酸(GABA)/总肌酸(tCr)升高(p<0.001)、谷氨酸/tCr降低(p<0.001)、肌醇/tCr升高(p<0.001)和总胆碱/tCr升高(p<0.001)。
  • 采样组织位置的2HG水平与总胆碱显著相关(R=0.62;p=0.002)、与总NAA显著相关(R=-0.61;p=0.002)、与细胞密度显著相关(R=0.37;p=0.04),但与MIB-1无关。
  • 2HG/tCr升高(p=0.0007,HR 5.594)及阈值(≥0.905,中位值;p=0.02)预测不良PFS。

关键数值与推荐

  • 2HG表观检出准确率为91.1%(39/42 IDH+和1/3 IDH-患者可定量)。
  • 2HG/tCr升高与不良PFS相关(p=0.0007,HR 5.594)。
  • 2HG/tCr≥0.905(中位值)与不良PFS相关(p=0.02)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Prognostically favorable IDH-mutant gliomas are known to produce oncometabolite D-2-hydroxyglutarate (2HG). In this study, we investigated metabolite-based features of patients with grade 2 and 3 glioma using 2HG-specific in vivo MR spectroscopy, to determine their relationship with image-guided tissue pathology and predictive role in progression-free survival (PFS). METHODS: Forty-five patients received pre-operative MRIs that included 3-D spectroscopy optimized for 2HG detection. Spectral data were reconstructed and quantified to compare metabolite levels according to molecular pathology (IDH1R132H, 1p/19q, and p53); glioma grade; histological subtype; and T2 lesion versus normal-appearing white matter (NAWM) ROIs. Levels of 2HG were correlated with other metabolites and pathological parameters (cellularity, MIB-1) from image-guided tissue samples using Pearson's correlation test. Metabolites predictive of PFS were evaluated with Cox proportional hazards models. RESULTS: Quantifiable levels of 2HG in 39/42 (93%) IDH+ and 1/3 (33%) IDH- patients indicated a 91.1% apparent detection accuracy. Myo-inositol/total choline (tCho) showed reduced values in astrocytic (1p/19q-wildtype), p53-mutant, and grade 3 (vs. 2) IDH-mutant gliomas (p < 0.05), all of which exhibited higher proportions of astrocytomas. Compared to NAWM, T2 lesions displayed elevated 2HG+ γ-aminobutyric acid (GABA)/total creatine (tCr) (p < 0.001); reduced glutamate/tCr (p < 0.001); increased myo-inositol/tCr (p < 0.001); and higher tCho/tCr (p < 0.001). Levels of 2HG at sampled tissue locations were significantly associated with tCho (R = 0.62; p = 0.002), total NAA (R = - 0.61; p = 0.002) and cellularity (R = 0.37; p = 0.04) but not MIB-1. Increasing levels of 2HG/tCr (p = 0.0007, HR 5.594) and thresholding (≥ 0.905, median value; p = 0.02) predicted adverse PFS. CONCLUSION: In vivo 2HG detection can reasonably be achieved on clinical scanners and increased levels may signal adverse PFS.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Autry AW, Lafontaine M, Jalbert L, et al. Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas. J Neurooncol. 2022. PMID: 35672531. doi:10.1007/s11060-022-04042-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。